# Align Technology Inc. (ALGN) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $158.63, market value $11.3 billion.

## Valuation
- **P/E (trailing): 27.5×** (5-yr avg 45.1×, 3-yr avg 37.3×). Align Technology Inc. trades at 27.5× trailing earnings, well below its own five-year average of 45.1×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 12.6×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 2.7×**. Each dollar of revenue is priced at 2.7×.
- **Price / book: 2.7×**. The shares trade at 2.7× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 5.6%** (5-yr avg 2.9%). Free cash flow equals 5.6% of the market value, above its five-year average of 2.9%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 3.6%**. The inverse of the P/E: 3.6% of the price is earned each year.

## Profitability
- **Gross margin: 68.0%**. Align Technology Inc. keeps 68.0% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 13.2%**. 13.2% of revenue is left after running the business.
- **Net margin: 10.2%**. 10.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.1%**. 10.1% on shareholders' equity is solid.
- **Return on assets: 6.6%**. Each dollar of assets produces 6.6% of profit.

## Growth
- **Revenue growth (1 yr): 0.9%** (3-yr 2.6%/yr, 5-yr 10.3%/yr). Revenue grew 0.9% over the last year, against 10.3% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 0.5%** (3-yr 7.0%/yr, 5-yr -24.1%/yr). Earnings per share rose 0.5%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 21.0%/yr**. Free cash flow has compounded at 21.0% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Current ratio: 1.36** (quick 1.36). Current assets cover the next year's liabilities 1.36 times.
- **Altman Z-score: 5.07**. A Z-score of 5.07 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Align Technology Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (15 analysts). 15 analysts cover Align Technology Inc.; the consensus is buy, with an average price target of $208.60 (+31% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 17.8%** (YTD 1.6%, 3-mo -5.4%). The shares are up 17.8% over twelve months including dividends.
- **From 52-week high: -20.9%** (30.0% above the low). Trading 21% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 42**. An RSI of 42 is neutral.
- **Beta (1 yr): 1.47** (volatility 39%). Beta of 1.47 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ALGN · Page: https://foliofundamentals.com/stocks/algn

Not investment advice.